AI Neural Network abstraction

Build intelligent experiences that feel human, fast, and effortless.

DeeboAI builds clinical intelligence software, risk assessment tools, and custom AI systems that help healthcare teams and operators move faster with more confidence. We turn high-stakes workflows into practical, production-ready products.

2

Current flagship healthcare products on the roadmap

1

Mayo Clinic-aligned risk assessment collaboration highlighted today

100%

Practical builds designed around real operator workflows

Scroll

About DeeboAI

Founded by Amadou Touré, DeeboAI is an applied AI company focused on clinical intelligence, risk assessment, and production-grade software for teams working in complex environments. Past work including Deebo Studio helped shape our product instincts, but today our focus is healthcare tooling and durable operator-facing systems.

Clinical AI

Risk assessment, medication intelligence, and decision-support software built for real healthcare workflows.

Healthcare

Patient-friendly transparency and clinician-aligned product design embedded into existing care systems.

Enterprise

Full-stack SaaS, analytics infrastructure, and custom software for operators scaling specialized services.

Mission-Driven

Every build starts with a real operator, clinician, or creative in mind.

Innovation First

Emerging research moves from lab to production through rapid experimentation.

People-Centric

We ship intuitive tools that scale without sacrificing human context.

Trajectory

From experimental AI builds to focused healthcare products.

Our throughline has stayed the same: build software around the actual workflow. That lesson carried from early product work into today's healthcare and decision-support platforms.

2023

MyelomaRisk Collaboration Begins

The underlying MyelomaRisk collaboration started before DeeboAI existed, laying the foundation for later clinical risk tooling work.

2024

Applied AI Product Work

Early work on products including Deebo Studio sharpened our approach to workflow-native AI and rapid product iteration.

2025

Healthcare Focus Deepened

Expanded clinical advisory and product discovery efforts around medication transparency and decision support.

2025

ZynthRx Platform Direction

Refined our medication intelligence platform around patient-friendly understanding, provider context, and workflow fit.

2026

MyelomaRisk Joins DeeboAI

The ongoing MyelomaRisk work was brought into DeeboAI's portfolio, connecting a 2023 clinical collaboration to the company's healthcare product direction.

Our Services

Strategic partners for teams building practical AI products from discovery through deployment.

AI Systems & Product Development

End-to-end ML product teams delivering automation, NLP, and predictive analytics.

  • Model architecture & training
  • MLOps, monitoring, compliance
  • Applied research sprints
From zero to production with measurable ROI in weeks, not quarters.

Experiential Web & Digital Platforms

High-impact marketing and corporate websites handcrafted without relying on AI.

  • Dynamic storytelling websites
  • Headless CMS + marketing ops
  • Accessibility + performance audits
Recent launch: Linque Resourcing — a hiring firm now booking more leads through linqueresourcing.com.

Industry SaaS & Integrations

Regulated-ready SaaS and data products for healthcare teams and specialized operators.

  • Clinical workflow tools
  • Event-driven integrations
  • Analytics & business intelligence
Current work spans ZynthRx, MyelomaRisk, and custom systems for high-context teams.

Workshop To Launch

Plug our founders directly into your product lifecycle for rapid discovery, design sprints, and technical validation.

Featured Products

Crafting intelligent solutions that free teams to focus on what matters.

In DevelopmentMedication Intelligence

ZynthRx

Patient-friendly medication intelligence layered into care workflows with clearer indications, context, and decision support.

Explore the roadmap
Active CollaborationClinical Risk Assessment

MyelomaRisk

Risk stratification and prognosis tooling for multiple myeloma and related plasma cell disorders, carried into DeeboAI in 2026 after the collaboration began in 2023.

Explore the roadmap
Custom BuildsServices

Need something purpose-built?

We partner with teams that need custom AI software, clinical workflow tools, and operator-ready systems rather than off-the-shelf demos.

Explore our services